A detailed history of Gries Financial LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gries Financial LLC holds 17,415 shares of BMY stock, worth $989,868. This represents 0.19% of its overall portfolio holdings.

Number of Shares
17,415
Previous 17,148 1.56%
Holding current value
$989,868
Previous $712,000 26.54%
% of portfolio
0.19%
Previous 0.17%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$39.66 - $51.75 $10,589 - $13,817
267 Added 1.56%
17,415 $901,000
Q2 2024

Aug 02, 2024

SELL
$40.25 - $52.99 $2.05 Million - $2.7 Million
-50,969 Reduced 74.83%
17,148 $712,000
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $1.26 Million - $1.43 Million
26,338 Added 63.04%
68,117 $3.69 Million
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $64,575 - $77,056
-1,332 Reduced 3.09%
41,779 $2.14 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $42,143 - $47,123
-728 Reduced 1.66%
43,111 $2.5 Million
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $28,542 - $31,691
-448 Reduced 1.01%
43,839 $2.8 Million
Q1 2023

Jun 21, 2023

SELL
$65.71 - $74.53 $128,068 - $145,258
-1,949 Reduced 4.22%
44,287 $3.07 Million
Q4 2022

Jan 10, 2023

BUY
$68.48 - $81.09 $610,225 - $722,592
8,911 Added 23.87%
46,236 $3.33 Million
Q3 2022

Oct 31, 2022

BUY
$0.13 - $76.84 $91 - $54,325
707 Added 1.93%
37,325 $2.65 Million
Q2 2022

Aug 16, 2022

SELL
$72.62 - $79.98 $734,478 - $808,917
-10,114 Reduced 21.64%
36,618 $2.82 Million
Q1 2022

Apr 29, 2022

BUY
$61.48 - $73.72 $571,764 - $685,596
9,300 Added 24.85%
46,732 $3.41 Million
Q4 2021

Feb 02, 2022

BUY
$53.63 - $62.52 $988,240 - $1.15 Million
18,427 Added 96.96%
37,432 $2.33 Million
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $8,875 - $10,396
-150 Reduced 0.78%
19,005 $1.13 Million
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $1.14 Million - $1.28 Million
19,155 New
19,155 $1.25 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Gries Financial LLC Portfolio

Follow Gries Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gries Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gries Financial LLC with notifications on news.